Xencor Q3 revenue falls to $10.7 million; net loss widens to $45.1 million
Xencor reported third-quarter 2024 results on November 6, 2024. Revenue fell to $10.7 million from $59.2 million a year earlier, and the net loss attributable to Xencor widened to $45.1 million, or $(0.71) per share, from $24.3 million, or $(0.40) per share. The company expects to end 2024 with between $690 million and $710 million in cash, cash equivalents and marketable debt securities.
Key points
- Revenue was $10.7 million for the quarter ended September 30, 2024, versus $59.2 million a year earlier, mainly non-cash royalty revenue from Alexion and Incyte.
- R&D expenses were $58.2 million, down from $64.9 million, while G&A expenses rose to $14.8 million from $12.5 million.
- Other income, net was $16.0 million, compared with other expense, net of $6.0 million a year earlier.
- Cash, cash equivalents and marketable debt securities were $754.3 million at September 30, 2024; year-end 2024 guidance is $690 million to $710 million.
The filing
Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 06, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.